OAM
ALXN
Origin Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-7,700
| Closed | -$1.42M | – | 137 |
|
2021
Q2 | $1.42M | Hold |
7,700
| – | – | 0.16% | 53 |
|
2021
Q1 | $1.18M | Sell |
7,700
-7,000
| -48% | -$1.07M | 0.12% | 67 |
|
2020
Q4 | $2.3M | Hold |
14,700
| – | – | 0.22% | 36 |
|
2020
Q3 | $1.68M | Sell |
14,700
-8,100
| -36% | -$927K | 0.18% | 42 |
|
2020
Q2 | $2.56M | Sell |
22,800
-1,900
| -8% | -$213K | 0.38% | 33 |
|
2020
Q1 | $2.22M | Sell |
24,700
-36,000
| -59% | -$3.23M | 0.29% | 38 |
|
2019
Q4 | $6.57M | Hold |
60,700
| – | – | 0.55% | 51 |
|
2019
Q3 | $5.95M | Sell |
60,700
-9,000
| -13% | -$881K | 0.54% | 54 |
|
2019
Q2 | $9.13M | Sell |
69,700
-35,500
| -34% | -$4.65M | 1.02% | 33 |
|
2019
Q1 | $14.2M | Buy |
105,200
+19,200
| +22% | +$2.6M | 1.19% | 38 |
|
2018
Q4 | $8.37M | Buy |
+86,000
| New | +$8.37M | 0.76% | 53 |
|
2018
Q1 | – | Sell |
-56,500
| Closed | -$6.76M | – | 132 |
|
2017
Q4 | $6.76M | Hold |
56,500
| – | – | 0.39% | 74 |
|
2017
Q3 | $7.93M | Buy |
+56,500
| New | +$7.93M | 0.49% | 64 |
|
2015
Q2 | – | Sell |
-39,292
| Closed | -$6.81M | – | 116 |
|
2015
Q1 | $6.81M | Hold |
39,292
| – | – | 0.5% | 73 |
|
2014
Q4 | $7.27M | Sell |
39,292
-23,208
| -37% | -$4.29M | 0.55% | 70 |
|
2014
Q3 | $10.4M | Hold |
62,500
| – | – | 0.67% | 61 |
|
2014
Q2 | $9.77M | Buy |
+62,500
| New | +$9.77M | 0.63% | 66 |
|